ChengDa Pharmaceuticals Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 260.26 million compared to CNY 305.65 million a year ago. Revenue was CNY 260.26 million compared to CNY 305.65 million a year ago.

Net income was CNY 61.18 million compared to CNY 92.05 million a year ago. Basic earnings per share from continuing operations was CNY 0.3955 compared to CNY 0.6119 a year ago. Diluted earnings per share from continuing operations was CNY 0.3955 compared to CNY 0.6119 a year ago.